The cost-effectiveness of sevelamer compared to calcium carbonate in the first-line treatment of hyperphosphataemia among new haemodialysis patients is presented in a patient-level, economic evaluation of the INDEPENDENT-HD study.
Sucroferric oxyhydroxide seems to be more cost-effective than sevelamer carbonate in hyperphosphataemia patients on dialysis who are intolerant to calcium-based phosphate binder based on a study from the perspective of the Scottish National Health Service.
Asian patients with end-stage renal failure (ESRF) had almost triple the risk of death within 1 year after hip fracture surgery, making ESRF an independent predictor for 1-year mortality, a recent study found.
The amount of added sugars in the diet, especially when present in processed foods, appears to increase the risk of frailty in older people, a recent study suggests. Low levels of physical activity and unintentional weight loss are the frailty components more closely associated with added sugars.